Roberta Bernardini
Impact in
- Molecular Medicine top 5%
- Curcumin's Biomedical Applications
Papers in
-
- MicroRNA in disease regulation 4
- Oncology 6
- Cancer Immunotherapy and Biomarkers 2
- Co-authors
- Maurizio Mattei (31 shared papers)Rosella Cicconi (6 shared papers)Luisa Campagnolo (5 shared papers)Monica Benvenuto (4 shared papers)Roberto Bei (4 shared papers)Micol Massimiani (4 shared papers)Graziana Palmieri (2 shared papers)Laura Masuelli (3 shared papers)
- Journals
- Cell Death and Disease (2 papers)Scientific Reports (2 papers)OncoImmunology (2 papers)Cancers (2 papers)Evidence-based Complementary and Alternative Medicine (1 paper)
- Partner nations
- ItalyUnited KingdomFrance
In The Last Decade
Roberta Bernardini
46 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 92
- Drug Discovery 4
- Molecular Medicine 80
- Biomaterials 75
- Immunology 114
- Cancer Research 75
Countries citing papers authored by Roberta Bernardini
This map shows the geographic impact of Roberta Bernardini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roberta Bernardini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roberta Bernardini more than expected).
Fields of papers citing papers by Roberta Bernardini
This network shows the impact of papers produced by Roberta Bernardini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roberta Bernardini. The network helps show where Roberta Bernardini may publish in the future.
Co-authors
The 25 scholars most cited alongside Roberta Bernardini, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 50 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 109 | |
| 2 | 2014 | 96 | |
| 3 | 2019 | 84 | |
| 4 | 2020 | 65 | |
| 5 | Curcumin induces apoptosis in breast cancer cell lines and delays the growth of mammary tumors in neu transgenic mice. | 2013 | 58 |
| 6 | 2017 | 48 | |
| 7 | 2018 | 48 | |
| 8 | 2013 | 47 | |
| 9 | 2019 | 46 | |
| 10 | 2012 | 43 | |
| 11 | 2020 | 40 | |
| 12 | 2017 | 39 | |
| 13 | 2024 | 37 | |
| 14 | 2019 | 34 | |
| 15 | 2020 | 32 | |
| 16 | 2018 | 31 | |
| 17 | 2020 | 30 | |
| 18 | 2017 | 24 | |
| 19 | 2018 | 23 | |
| 20 | 2019 | 20 |
About Roberta Bernardini
Roberta Bernardini is a scholar working on Cancer Research, Oncology, Infectious Diseases, Immunology and Molecular Medicine, having authored 50 papers that have together received 1.2k indexed citations. Recurring topics across this work include Tuberculosis Research and Epidemiology (5 papers), MicroRNA in disease regulation (4 papers), Advanced Drug Delivery Systems (3 papers), Nanoparticle-Based Drug Delivery (3 papers), Curcumin's Biomedical Applications (3 papers), Carbohydrate Chemistry and Synthesis (3 papers), Immunotherapy and Immune Responses (3 papers) and Cancer Immunotherapy and Biomarkers (2 papers). The work is most often cited by research in Drug Discovery (4 citations), Molecular Medicine (80 citations), Biomaterials (75 citations), Immunology (114 citations) and Cancer Research (75 citations). Roberta Bernardini has collaborated with scholars based in Italy, United Kingdom and France. Frequent co-authors include Maurizio Mattei, Rosella Cicconi, Luisa Campagnolo, Monica Benvenuto, Roberto Bei, Micol Massimiani, Graziana Palmieri, Laura Masuelli, Andrea Magrini and Lucia Vecchione. Their work appears in journals such as Cell Death and Disease, Scientific Reports, OncoImmunology, Cancers and Evidence-based Complementary and Alternative Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.